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Abstract
The pancreatic stellate cells (PSCs) have complex roles in pancreas, including tissue repair and fibrosis. PSCs surround ATP
releasing exocrine cells, but little is known about purinergic receptors and their function in PSCs. Our aim was to resolve
whether PSCs express the multifunctional P2X7 receptor and elucidate how it regulates PSC viability. The number of PSCs
isolated from wild type (WT) mice was 50% higher than those from the Pfizer P2X7 receptor knock out (KO) mice. The P2X7
receptor protein and mRNA of all known isoforms were expressed in WT PSCs, while KO PSCs only expressed truncated
versions of the receptor. In culture, the proliferation rate of the KO PSCs was significantly lower. Inclusion of apyrase
reduced the proliferation rate in both WT and KO PSCs, indicating importance of endogenous ATP. Exogenous ATP had
a two-sided effect. Proliferation of both WT and KO cells was stimulated with ATP in a concentration-dependent manner
with a maximum effect at 100 mM. At high ATP concentration (5 mM), WT PSCs, but not the KO PSCs died. The intracellular
Ca2+ signals and proliferation rate induced by micromolar ATP concentrations were inhibited by the allosteric P2X7 receptor
inhibitor az10606120. The P2X7 receptor-pore inhibitor A438079 partially prevented cell death induced by millimolar ATP
concentrations. This study shows that ATP and P2X7 receptors are important regulators of PSC proliferation and death, and
therefore might be potential targets for treatments of pancreatic fibrosis and cancer.
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Introduction
ATP is an extracellular signal that stimulates purinergic
receptors in many different tissues. In pancreas ATP is released
from acinar cells, pancreatic duct cells and from b-cells [1–3]. In
1998, a novel cell type was discovered in pancreas, namely the
pancreatic stellate cell, PSC [4,5]. The importance of the PSCs
function in pancreas is becoming apparent, especially in the
context of pancreatic disease such as chronic pancreatitis and
pancreatic cancer [6]. Little is known about PSCs physiology and
the role of purinergic signaling in these cells.
PSCs have a mixed phenotype and a protein expression profile
overlapping with several different cell types. They express a smooth
muscle actin (aSMA), which is typically expressed in fibroblasts
that are able to contract, and glial fibrillary acidic protein (GFAP),
an intermediate filament protein of astrocytes. These proteins are
therefore not specific to PSCs, however, their combination,
together with vitamin A rich lipid granules in freshly isolated
cells, are specific markers for PSCs [4]. Similar stellate cells are
found in many tissues in the body and the best characterized are
the cells originating from the liver, named hepatic stellate cells [7].
In a healthy pancreas, PSCs are inactive and surround
predominantly acinar cells. Only a few PSCs are found around
ducts [8]. Upon pancreatic damage, metabolic stress and
pancreatic cancer, PSCs become activated by growth factors/
cytokines released from the neighboring cells [9,10]. The activated
PSCs then participate in wound healing. Subsequently, they either
retreat via apoptosis or remain continuously activated. The latter
scenario gives rise to pancreatic fibrosis [10,11].
There are two main families of purinergic receptors for ATP:
the P2Y receptor family of G-protein coupled receptors and the
P2X receptor family of ligand-gated ion channels. The P2X
receptors are annotated P2X1–P2X7 [12]. One of the most
multifaceted receptors is the P2X7 receptor, which has a large
intracellular C-terminal and forms a cation channel at micromolar
ATP concentrations. At higher concentration of ATP, in the
millimolar range, the receptor can open as a pore permeable to
molecules up to 900 Da [13,14]. This leads to apoptosis/necrosis,
and therefore the receptor has been named the death receptor
[15–17]. However, experiments by Baricordi et al. [18] indicated
that the receptor has also proliferation determining properties
when expressed in lymphoid cells. This behavior could occur at
lower ATP concentrations and is most likely not due to pore-
forming abilities of the receptor. The P2X7 receptor in rodents
and humans exists in many different isoforms: in rodents the full
length A (595 amino acids - aa) and K (592aa) isoforms with
different starting exons, two C-terminally truncated versions
named B (431aa) and C (442aa), and isoform D with only one
transmembrane domain (153aa) [19]. Adinolfi et al. [20] suggested
that the truncated isoform B stimulate proliferation in transfected
HEK293 cells. Furthermore, expression of both A and B isoforms
leads to additive effects on proliferation. A number of studies show
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that the P2X7 receptor stimulates a variety of cell responses and
there are a number of SNPs that are associated with human
disease [21,22].
In pancreas, there are number of P2 receptors on exocrine and
endocrine cells [1,3]. In samples from patients suffering from
chronic pancreatitis, or from mouse models of this disease, CD39,
P2Y2 and P2X7 receptors were upregulated [23,24]. However,
the expression of the P2X7 receptor in PSCs is unsettled, as the
experimental evidence is contradicting or incomplete; expression
of the receptor was claimed by Ku¨nzli et al. but Hennigs et al.
could not detect any expression [24,25]. In another study, Won
et al. [26] illustrated that ATP increases calcium signals in the
nucleus of PSCs and this event was independent of extracellular
calcium, implicating a P2Y type receptor.
The regulation of PSCs viability and function is highly relevant
for many pancreatic diseases and we hypothesized that the P2X7
receptor could be an important element in this regulation. The
aim of our experiments was to determine the expression of the
P2X7 receptor and its effect on proliferation and/or death in
freshly isolated PSCs. For this purpose we further developed and
simplified the isolation method of PSCs that were obtained from
WT and the Pfizer P2X7 receptor KO mice [27]. The
experiments presented here show that the proliferation of PSC is
dependent on the P2X7 receptor and on ATP concentrations,
such that ATP can function as a promoter of proliferation at
micromolar concentrations. At millimolar concentrations, howev-
er, ATP is lethal to PSCs.
Methods
Isolation of Cells
P2X7 KO and WT mice were bred from Pfizer
(NOD.129P2(B6)-P2rx7tm1Gab/DvsJ) on the C57BL/6JBom back-
ground. Additional WT mice were purchased from Taconic
(C57BL/6JBomTac). Mice of mixed gender weighing approxi-
mately 20 g were used in this study. For comparison experiments
WT and KO mice were littermates. Procedures were approved by
the Danish Animal Experiment Inspectorate (Dyreforsøgstilsynet).
All isolation steps were carried out to minimize the risk of
contamination. The pancreata from P2X7R (P2X7 Receptor) KO
and WT mice were removed after the mice were killed with
cervical dislocation. Connective tissue and fat were removed and
the pancreas was cut into pieces in physiological Ringer. Isolation
media contained DMEM and F12 (1:1), 5 mM HEPES, 1 mg/ml
Albumin, 2 mM CaCl2 and 5 mM Glycine, gassed with 5% CO2
and pH adjusted to 7.4. The small pieces were incubated in 5 ml
of media containing 6 mg of Collagenase V (Sigma C9263), gassed
with 5% CO2, 20% O2 and 75% N2 for 50 minutes at 37uC.
Digested pieces were dispersed by vigorous pipetting with a glass
pipette. The cell suspension was then centrifuged at 1000 g for 8
minutes. The media was changed and the cells were resuspended
and added to a 10 cm plastic dish (NUNC) that was coated with
1 ml of FCS. After three hours, the dish was washed with media,
and PSCs were the only cells that attached strongly. PSCs then
appeared as small dark spots, some having small protrusions. The
DMEM media (10% serum and Pen Strep, Invitrogen) was
changed daily the first two days.
Immunocytochemistry
PSCs were split and allowed to attach to glass coverslips
overnight. The cells were fixed in 4% paraformaldehyde in PBS
for 15 min, treated with 0.2 M TRIS-glycine (pH 7.4) for 15 min;
then rinsed in PBS and permeabilized for 10 min in PBS 0.5%
TritonX-100. The samples were blocked with 10% BSA in PBS
for 45 minutes and then incubated with the primary antibodies for
P2X7R (1:100, 8 mg/ml, Alomone APR 004), aSMA (1:400
Sigma A2547) or GFAP (1:200 Sigma G9269) overnight at 4uC.
The slides were then washed in PBS and incubated for 1 hour with
1:400 dilution of appropriate secondary antibody conjugated to
Alexa 488 or Alexa 568. For nuclear staining, DAPI was used
(1:400, 1 mg/ml). Fat droplets were stained with 5 mM Nile Red
(Sigma 72485) in 75% glycerol for 15 minutes and washed. Finally,
the coverslips were washed in distilled water and mounted with N-
propyl-gallate on slides. Fluorescence was examined with 406
1.3 NA objective in Leica (TCS SP 5X MP) confocal laser
scanning microscope (Leica Microsystems A/S, Heidelberg).
RNA Isolation and PCR
Cells were cultured to confluence and then RNA was isolated
with RNeasy Mini Kit (Qiagen 74104 Briefly, cells lysates were
precipitated with 1 volume of 70% ethanol and column purified.
The RNA was treated with DNase 1 (RNase free DNase Set,
Qiagen 79254). 300 ng of extracted RNA was used per reaction
mixture in QIAGEN OneStep RT-PCR Kit (210212) analysis,
with amplification parameters as follows: one cycle at 50uC for
30 min and one cycle at 95uC for 15 min followed by 40 cycles at
95uC for 30 s, 58uC for 30 s, 72uC for 30 s, and finally, one cycle
at 72uC for 10 min. Subsequently, all transcripts were subjected to
electrophoresis on 1.2% agarose gels. Table 1 shows primers used;
these were synthesized by TAG Copenhagen A/S (Copenhagen,
Denmark). All primers were designed using Primer-BLAST
(NCBI) with an expected Tm of 60uC, annealing temperature
was selected to be 2uC below this Tm.
Western Blot
Protein lysates were created by adding 56 lysis buffer (250 mM
TrisBase, 1.25 M NaCl, 50 mM EDTA, 5% Triton X-100,
20 mM NaF) to the PSCs. Cell lysates were centrifuged at
15,000 g for 15 min. Western blot samples were either not
reduced or reduced by heating to 90uC in the presence of 50 mM
DTT (dithiothreitol) for 10 minutes and run on precast gels from
Invitrogen. The membrane was blocked overnight at 4uC in 0.5%
milk powder and 1% BSA together with 0.1% Tween 20. Primary
antibody for P2X7R (1:200, 4 mg/ml, Extracellular; Alomone
APR 004, 1:100, 2 mg/ml, C-terminal; Santa Cruz sc-15200) was
added in blocking buffer for 1 hour. The appropriate secondary
antibody conjugated to horse-radish peroxidase (1:2000) was
added in blocking buffer for 1 hour. Enzyme substrate was added
and blots were viewed on a Fusion FX Vilber Lourmat.
Video Microscopy
Isolated cultured PSCs were seeded onto collagen coated
culture flasks (0.031 mg/mL Laminin, 0.031 mg/ml Fibronectin
and 0.18 mg/mL Collagen IV) and attached for 3 hours.
Subsequently, the DMEM medium was exchanged with Ringer’s
solution containing in mM: 122.5 NaCl, 5.4 KCl, 0.8 MgCl2, 1.2
CaCl2, 1 NaH2PO4 5.5 Glucose and 10 HEPES. The culture
flasks were placed in a heating chamber at 37uC of an inverted
Axiovert 25 (Carl Zeiss). Cell images were recorded using video
cameras (models XCST70CE and XC-77CE, Hamamatsu/Sony)
and PCvision frame grabber boards (Hamamatsu, Herrsching).
Acquisition of images was controlled by HiPic and WASABI
software (Hamamatsu). PSCs were left to rest for 30 minutes, and
then stimulated with 5 mM ATP. Images of cells were taken every
two minutes for 10 hours. Images selection and videos were made
using ImageJ.
P2X7 - Life and Death in Pancreatic Stellate Cells
PLOS ONE | www.plosone.org 2 December 2012 | Volume 7 | Issue 12 | e51164
Calcium Signals
PSCs were seeded in Wilco dishes with optical glass bottom.
Cells were incubated with 5 mM Fluo-4AM (Invitrogen) in 15
minutes. PSCs were pre-incubated with suramin (100 mM),
az10606120 (10 mM) or vehicle solutions 30 min before the
experiment. PSCs were stimulated with 50 mM 2’(3’)-O-(4-
Benzoylbenzoyl)adenosine-5’-triphosphate (BzATP), 50 mM
ATP, and 5 mM ionomycin, sequentially. Fluo-4 was excited at
488 nm with an Argon laser and fluorescence was collected at
500–570 nm using a PL Apo 206 NA 0.7 objective on Leica
confocal/multiphoton microscope. Cells were kept at 37uC in
physiological solutions containing in mM: 140 NaCl, 1 MgCl2, 1.5
CaCl2, 0.4 KH2PO4, 1.6 K2HPO4, 10 Glucose and 10 HEPES.
Image analysis was performed in LAS AF software with 5 single
cell responses shown in the figure together with the collective
response from circa 50 cells per preparation and evaluated by
whole frame analysis. Fluo-4 intensity is given as fluorescence ratio
at time t in relation to time 0 (Ft/F0); and in response to agonists
as DFt/F0.
Cell Death Assays
ATP (5 mM) was added to PSCs that had been seeded in Wilco
glass dishes. After 5 hours, annexin V FITC conjugated antibody
(Sigma APOAF) was added together with the dye propidium
iodide for 10 minutes and pictures were taken using Leica SP 5X
MP microscope. Annexin V was exited at 488 nm and emitted
light collected at 500–570 nm; propidium iodide was excited at
488 nm and emission was collected at 600–700 nm sequentially.
In one series of experiment, Caspase 3/7 activation (Promega,
Caspase-Glo 3/7 assay) was measured according to the instruc-
tions of the manufacturer.
Cell Proliferation
Cells were isolated and grown on plastic dishes for 7 days, which
led to their activation. The activated PSCs were split and added to
96 well plates (COSTAR) at 5000 PSCs/well. After attachment for
24 hours in 10% serum, the media was changed to that containing
the indicated concentration of serum together with ATP and/or
other agonists/antagonists. The PSCs were then left undisturbed
for 48 hours. During the last 4 hours, cells were incubated with the
reagents from ROCHE (BrdU) or DOJINDO (Cell Counting Kit
8) and processed according to the manufacturer9s instructions and
with appropriate controls. Chemiluminescence and absorbance
were measured in Fluostar OPTIMA. All manual cell-counting
was done using a counting chamber or dish area in the
microscope. All measurements were performed in either duplicates
or triplicates.
The cell counting kit was used in the experiments where
proliferation over many days was monitored in living cells due to
limited toxicity. BrdU incorporation that monitors the actual DNA
synthesis requires that the cells are fixed. This method has higher
sensitivity and most data shown in the result section were
performed with the BrdU kit. Experiments with Cell Counting
kit 8 were done in parallel to these and showed similar results in all
experiments.
Chemicals and Statistics
All chemicals/kits were purchased from Sigma-Aldrich unless
otherwise states. The inhibitors A438079 and az10606120 were
both purchased from TOCRIS Bioscience. Data are shown as
means 6 SEM, n denotes a number of experiments on cells
isolated from different animals. Students paired t test was applied
when comparing two samples from the same animal and P,0.05
was accepted as significant. For comparison of responses to various
agonists Dunn’s test in one-way Analysis of Variance (ANOVA) on
Ranks was used. Data were analyzed in Origin or Microsoft Excel.
Results
Characterization of PSC Preparation and Morphology
The two common methods for PSCs isolation make use of either
a centrifugation gradients [4] or an outgrowth method [5]. The
centrifugation method employs the low density of PSC in
a Nycodense gradient to separate the cells. For the outgrowth
method, pancreatic pieces are allowed to stay in media for longer
time and PSCs migrate out of the tissue and proliferate. We aimed
to simplify and scale down the isolation method for a single mouse
pancreas. Therefore, we developed a method where PSCs were
Table 1. Primer sets used for RT-PCR on PSCs for isoforms A–D and K, and within the deleted area (Intra) and spanning the deleted
area (Spanning).
Primers Sequence Product length
P2X7 A FW TGCACTCTTGAGGAGCGCCGA 218
P2X7 A RW TGATTCCTCCCTGAACTGCCACCT
P2X7 B FW GCCGCACATTCGCATGGTGG 247
P2X7 B RW TGGCTGAATGGTTACGACCACTTGCT
P2X7 C FW TGCTTTCTGCAGGTCGGGGGT 228
P2X7 C RW GAAACAAGTATCTAGGTTGGAACTTCTTGGCC
P2X7 D FW ACACCTTCCCTTTGCAGGGGAACT 197
P2X7 D RW GGCAGCAGAACTTTAGGCCAGCT
P2X7 K FW GGATCGGGACGCTGAAGAACAC 173
P2X7 K RW CTTCGTCACCCCACCCTCTGTGA
P2X7 Intra FW TCCAAGCTCTTCCATAAGCTCGTGC 70
P2X7 Intra FW AGGGATCCTGGTAAAGCAGGAGGAG
P2X7 Spanning FW GCCCGAGTTGGTGCCAGTGT 223
P2X7 Spanning FW TGTCGCAGCCTGCTGTTGGT
doi:10.1371/journal.pone.0051164.t001
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isolated using a combination of collagenase digestion and selective
attachment. PSCs appear to have the ability to utilize the
fibronectin in fetal calf serum for early attachment, as is the case
for many cell types [28]. Therefore, PSCs attached quickly to the
dish compared to ducts, acinar and islets cells, which did not
attach to the dish in the first three hours. The stellate cell
population obtained was uniform and showed clear lipid granules
that could be detected up to day 2 (Fig. 1A). After 7 days, PSCs
were activated and expressed clear a-SMA and also GFAP
staining (Fig. 1B–C).
The Expression of the P2X7 Receptor in PSCs
We examined the P2X7 receptor expression using PCR,
immunocytochemistry and Western Blot on WT and Pfizer KO
samples. First, we investigated the mRNA content of the PSCs.
The primer sets for PCR are given in Table 1. The creation of the
Pfizer P2X7 receptor KO mice was made by inserting a Lox-
NeoR-Promoter-Lox into the C-terminal instead of bp 1675 to bp
1760, this introduces an early stop codon truncating the C-
terminal affecting isoforms A and K [27]. The map of isoforms
and mRNA present in WT and KO is shown in Fig. 2. In the
original paper, Solle et al. did not observe any mRNA in
macrophages [27]. Fig. 3A shows that mRNA for all the mouse
isoforms A–D and K are expressed WT PSCs. Surprisingly, in
PSCs from Pfizer KO the mRNA for the exons downstream of the
inserted neomycin box were still expressed, while the deleted area
(P2X7R Intra) and the fragment amplified by primers spanning
the insertion (P2X7R Spanning) were not present, as seen in the
WT preparations. Nevertheless, the insertion of the NeoR part did
lead to disruption of this part of the mRNA. Both the complete B
and C isoform mRNAs of the P2X7 receptor are present in PSCs
from KO (Fig. 3A). Also mRNA for the KO truncated P2X7
receptor isoform A (527aa) and K (524aa) with an early stop codon
was detected (data not shown). This KO isoforms A and K hybrids
were also reported by Masin et al. [29].
To determine whether any of the mRNA of the subtypes
resulted in protein, we examined the protein expression using
antibodies against the extracellular domain or the C-terminal part
of the P2X7 receptor. Fig. 3B shows images of WT and KO PSCs
labeled with the P2X7 receptor extracellular antibody, which
labels intracellular vesicles and has a weaker but clear plasma
membrane staining observed only in WT (see insert). The
antibody against the C-terminus of the P2X7 receptor did not
give any significant staining of the cells (data not shown). The same
two antibodies were used for detecting the P2X7 receptor in
a Western Blot in reducing and non-reducing conditions (Fig. 3C).
Loading control (aSMA) was included for both blots. The
expected size of a full length receptor monomer of the P2X7
receptor is 75 kDa and this is detected in WT with both antibodies
(Fig. 3C, left and right panels). As seen in the figure, the
extracellular antibody (left) also recognized a ,450 kDa protein in
non-reducing conditions in both WT and KO PSC samples; the
band disappeared in the reduced sample and the 130 kDa band
became more intense. These large proteins could be either P2X7
receptor trimers and/or a multiprotein complex, or a potential
unspecific binding. Proteins of similar size have been reported by
Kim et al. [30] and Masin et al. [29]. Importantly, the band for the
shorter receptor isoform is expressed both in WT and KO and it is
detected at about 60 kDa in reduced conditions only. This is most
likely the isoform B or C. The C-terminal antibody (Fig. 3C, right)
recognizes only the band at 75 kDa, demonstrating the full length
P2X7 receptor monomer. Clearly, the C-terminus of P2X7
receptors is disrupted in KO PSCs and no protein was detected.
Also the clear bands at 130 kDa and 450 kDa, which were
sensitive to reducing conditions, were not obvious with the C-
terminal antibody (Fig. 3C left and right panels).
Differences in Cell Death in WT and KO PSCs
The mRNA data together with Western blot and immunocy-
tochemistry illustrated that several isoforms of the P2X7 receptor
are expressed in KO PSCs, including a truncated isoform K that
escaped in the Glaxo KO [19]. However, this isoform must also be
truncated in KO cells, as its last exon is the same as for isoform A.
Therefore, we investigated whether the P2X7 receptor expressed
in KO cells induced cell death, as is known to be the case for the
full length A and K isoforms, presumably due to their pore-
forming capabilities. Behavior of WT and KO PSCs was
monitored by video microscopy in an environmentally controlled
chamber for 10 hours. Without exogenous ATP, there was no
significant death observed in the KO cells, nor in the WT PSC
(Fig. 4A). The video capture in Fig. 4A shows that after the
addition of 5 mM ATP, 72.5612% (n= 5 independent experi-
ments) of WT PSCs died within 10 hours compared with only
3.662% (n= 5) of KO PSCs. The data summarizing PSC death
Figure 1. PSC phenotype. A. Nile red lipid staining at day 2. B. aSMA antibody staining at day 7. C. GFAP antibody staining at day 7. Secondary
antibody was conjugated to Alexa 488 (green) and nuclear stain was DAPI (blue). Representative images of 3 independent experiments. Scale bars are
50 mm.
doi:10.1371/journal.pone.0051164.g001
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for WT and KO PSC is shown in Fig. 4B. These data clearly
shows that the WT PSCs express functional P2X7 receptors that
form cytolytic pores at 5 mM ATP. The P2X7 receptor protein
that is expressed in KO PSCs, however, is not sufficient to cause
pore opening and the following cell death. Since the cell death in
WT cells visually appeared to have similarities with necrosis rather
than apoptosis, we investigated which type of cell death might be
initiated with high ATP concentrations. Using annexin-V FITC
conjugated antibody together with propidium iodide, it is evident
that the cells appear necrotic (Fig. 4C). In another assay we used
apoptotic markers, caspase 3/7, and did not observe any
significant activation after 5 hours (Fig. 4D), further supporting
the notion that PSCs die by non-apoptotic, likely necrotic death.
Importantly, the cell death that was initiated with 5 mM ATP
could be inhibited by about 50% with the competitive P2X7
receptor-pore inhibitor A438079 at tested concentrations (Fig. 4E).
These data show that the P2X7 receptor is important for initiating
the cell death.
Cell Numbers and Proliferation of PSCs
We compared the number of PSCs isolated from WT and KO
animals. Fig. 5A shows that the number of PSCs isolated from KO
was about 50% lower than the number of cells isolated from same
amount of WT pancreas tissue (n = 10). Next we tested whether
this difference in cell numbers is due to the differences in the
proliferative potential of the PSC. The experiments were
conducted to monitor cell proliferation rate in vitro. After isolation,
PSCs from WT and KO animals were immediately split and re-
seeded in 96 well plates with a density of 2500 cells/well. The cells
were grown in 10% serum and the proliferation was determined
with Cell Counting Kit 8 for a period of 8 days. The Fig. 5B shows
that with the same seeding numbers, after first two days the growth
of PSC from the KO mice lagged greatly behind the PSC from
WT mice. The WT PSCs grew with a doubling time of 1.7 days
and KO PSCs at 2.2 days, as calculated using the best fit
exponential growth. Clearly, KO PSC had less proliferation
potential. Since, there are several isoforms of the receptor
expressed in KO PSCs (see Fig. 3), this finding indicates that the
full length P2X7 receptor protein is required for the full
proliferation effect.
The above experiments indicated that the P2X7 receptor could
be important in regulating proliferation, therefore we postulated
that by providing exogenous ATP we could further increase
proliferation rate of PSCs. During the activation phase from day
0 to day 9, 100 mM ATP or the P2X7 receptor agonist 100 mM
BzATP was included. The agonists were added to the cells daily
when media was changed after Cell Counting Kit 8 measure-
ments. However, addition of the agonists did not cause any
difference in proliferation (data not shown). These experiments
were carried out using 10% serum, so that effects of exogenously
added ATP could have been masked by: (i) the stimulation of
proliferation caused by the high serum; (ii) endogenous ATP
release caused by daily medium changes; (iii) and not the least,
changes in cells from inactive to active states. Therefore, we
decided to simplify the protocols and work with activated PSC,
lower serum concentrations and use the more sensitive BrdU kit. It
became clear that as for many other cells, serum is important for
PSC survival and proliferation. That is, 10% serum increased
BrdU incorporation in PSCs to 386651% (n= 4) compared to the
1% serum that was chosen as control for the following
experiments.
ATP Affects Both Life and Death of Activated PSCs
To investigate whether endogenous ATP and the P2X7
receptors were necessary for the proliferation of PSCs, we
designed an experiment where cells were grown in the presence
of apyrase, an enzyme that breaks down ATP/ADP to AMP.
PSCs were grown in the presence of 1% serum, and proliferation
of activated PSC cells (grown 7 days on plastic dishes) from WT
and KO mice was determined using BrdU incorporation. Fig. 6A
shows that KO PSCs proliferated significantly slower than WT
cells, which confirmed the results obtained using different
Figure 2. Gene map of the P2X7 receptor isoforms. The map is made according to the NCBI reference sequences. Exons are numbered and
start/stop codon are marked. The map illustrates the potential mRNA isoforms that detected in mouse PSCs. These are marked in light grey for both
WT and KO samples. Expected KO isoform A and K hybrids are also depicted, with the NeoR cassette inserted in white and the inserted early stop
codon labeled.
doi:10.1371/journal.pone.0051164.g002
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protocols (Fig. 5). In the presence of apyrase (5 U/ml), the
proliferation rate was reduced in both WT and KO PSCs to
similar levels. The cells did not die, but only stopped proliferating
as indicated by measurements with the cell counting kit (data not
shown).
We next tested whether ATP promotes proliferation in WT
PSCs and whether it is independent of serum factors. All results
were normalized to the proliferation rate with 1% serum set to
100%. Fig. 6B illustrates proliferation in 0% serum as BrdU
incorporation was 4265% (n= 17). For comparison, in 1% serum
apyrase reduced BrdU incorporation to 2464% (n= 12). Addition
of exogenous ATP (100 mM) to serum-free medium did not
change the proliferation rate of PSCs, i.e. BrdU incorporation was
3566% (n= 6). However, addition of 5 mM ATP resulted in
death of PSCs; BrdU incorporation was 262% (n= 6).
On the basis of the apyrase experiments, we concluded that
endogenously released ATP could act as an autocrine proliferation
potentiator for the activated PSCs in both WT and KO. We
therefore hypothesized that exogenous ATP could further
stimulate proliferation in 1% serum. Therefore, we tested the
effect of increasing concentrations of ATP from 1 mM to 5 mM.
The results shown in Fig. 7A were normalized to a 1% serum
control without exogenous ATP. In WT PSCs, ATP stimulated
proliferation in a concentration-dependent manner with a maxi-
mum effect at 100 mM (151610%, n= 19). Higher concentrations
of ATP did not stimulate proliferation, they actually lowered the
Figure 3. Expression of the P2X7 receptor in PSCs. A. PCR results from PSCs isolated from WT and KO mice illustrate the presence of all
isoforms A–D and K; mRNA transcripts are also present in KO. The area disrupted by homologous recombination (In) is, however, absent. Similarly, the
area spanning the disrupted area (Sp) is missing. B. Immunostaining of PSCs with primary antibody for the extracellular domain of the P2X7 receptor.
Scale bar is 10 mM. C. Western blots on whole cell lysate with antibody against an extracellular domain (ex-dom) and the C-terminal part of P2X7 (C-
term) in reducing (r) and non-reducing conditions. The loading control was aSMA and this blot was exposed for shorter times. Representative of 3
independent experiments.
doi:10.1371/journal.pone.0051164.g003
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DNA synthesis significantly at 1 mM (72614%, n=17). At 5 mM
ATP, the DNA synthesis was greatly reduced (2965%, n= 6)
(Fig. 7A). Also the cell number was reduced, as confirmed by cell
counting (data not shown).
In the following experiments, we determined the effect of ATP
on BrdU incorporation in KO PSC and compared them to WT
data. The raw value for WT PSC in 1% serum zero ATP control
was 983961570 relative light units (RLU) and for KO PSCs it was
459661403 RLU (n= 23 and 7). Due to this difference between
Figure 4. Cell death of PSCs in the presence of 5 mM ATP. A. Behavior of PSCs isolated from WT and KO was monitored for 10 hours; and
pictures were taken at 2 min intervals. A. Representative phase contrast images of the PSCs at 0 hours, 5 hours and 10 hours. The top lane are WT
cells and the bottom lane are KO cells. B. The bar graph summarizes the number of cells that died in control conditions or after addition of 5 mM ATP
(n = 4–5 independent experiments). C. AnnexinV-FITC and propidium ioidide stain was added 5 hours after addition of 5 mM ATP to WT cells. D.
Caspase 3/7 activation 5 hours after cells were stimulated with 5 mM ATP. E. BrdU incorporation measured 48 hours after the addition of 5 mM ATP.
BrdU incorporations were normalized to 1% serum conditions. Significant difference (P,0.05) from respective controls (#) and between WT and KO
(*) is indicated.
doi:10.1371/journal.pone.0051164.g004
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WT and KO, the controls were normalized so that ATP effects
could be compared. As the results in Fig. 7B show, ATP stimulates
proliferation in activated PSCs, both in WT and KO samples.
This occurs in a concentration-dependent manner and 100 mM
ATP gave the highest response in both types of cells with
151610% increase for WT and 182630% increase for KO,
n=19 and 17 (Fig. 7B). When the ATP concentration was
increased further, there was a significant difference between
proliferation of WT and KO PSCs. It is apparent that the KO
PSCs did not die at high ATP concentrations of 1 mM, where
their proliferation was 152635% of the control compared to WT
PSCs that had already reduced proliferation with values of
7467% of the control (n = 7 and 17). At the highest ATP
concentration tested (5 mM), there was a huge reduction of BrdU
incorporation to 2965% in WT PSCs, compared to 72614% in
KO PSCs, the latter being not significantly different to the control
(n = 6 and 7).
Since the above experiments pointed towards the importance of
the P2X7 receptor in life and death of PSCs, we postulated that
a P2X7 receptor stimulant or inhibitor could affect the ATP
stimulated proliferation. We therefore tested the effect of the
prototypic P2X7 receptor agonist BzATP. Fig. 8A shows that
BzATP increased the proliferation to 148617% (n= 6) of the
control at 10 mM and to 233646% (n= 6) at 100 mM. Thus,
10 mM BzATP elicited a similar effect on cell proliferation as
a tenfold higher ATP concentration. There also seemed to be
a small increase of proliferation in KO PSCs at 10 mM BzATP
(143623%, n= 7) and at 100 mM (140630%, n= 7), though no
statistical significance was achieved. This observation could
indicate that the P2X7 receptor isoforms expressed in KO cells
do not respond well to BzATP.
The P2X7 receptor inhibitor A438079 is a competitive
antagonist for P2X7 receptor specifically designed to prevent pore
formation. When this antagonist (10 mM) was added 30 minutes
before growth-stimulation by 100 mMATP, or to PSCs growing in
1% serum, it did not show any significant effects (Fig. 8B).
Therefore, we applied a non-competitive inhibitor, az10606120.
This blocker binds in a positive cooperative manner to sites distinct
from, but coupled to the ATP binding site and acts as a negative
allosteric modulator [31]. Az10606120 (10 mM) was highly
efficient in our experiments and inhibited the PSCs growth to
1968% (n= 4) compared to 1% serum control (without exogenous
ATP). The proliferative promoting effect of 100 mM ATP was also
significantly reduced from 162625% to 37612% (n= 4) with this
inhibitor.
Finally, in order to obtain another evaluation of functional
P2X7 receptor expression in WT and KO cells, calcium imaging
was performed. Intracellular Ca2+ responses to BzATP (50 mM)
and ATP (50 mM) and receptor inhibitors az10606120 (10 mM)
and suramin (100 mM) were tested. Ionomycin (5 mM), a Ca2+
ionophore, was added in the end of the experiment as a positive
control. Fig. 9 shows that there were significant differences in
responses obtained from WT and KO cells. First of all, PSC from
KO animals showed significantly smaller responses to BzATP. In
WT cells BzATP changed the Fluo-4 intensity to 2.560.23 and
az10606120 inhibitor (10 mM) lowered the response significantly
to 1.660.25 (n= 4)(Fig. 9A, B). In KO cells, BzATP also elicited
Ca2+ signals, Fluo-4 intensity increased to 1.060.15, and
importantly, the az10606120 inhibitor had no further effects; i.e.
Fluo-4 intensity was 1.360.24 (n= 4)(Fig. 9 E, F). This finding
indicates that the az10606120 sensitive P2X7 receptor (isoform)
remaining in PSCs from KO pancreas was not functional. In order
to eliminate possible responses from other P2X and P2Y receptors,
we added a broad spectrum inhibitor suramin at such a high
concentration (100 mM) that most purinergic receptors would be
blocked, and presumably only P2X7 responses would be visible
(Fig. 9 C, G). Indeed, suramin inhibited the BzATP effect on Ca2+
signals completely in KO PSCs as Fluo-4 intensity remained at the
baseline 0.060.02. In contrast, WT cells still had significant
response (0.760.23, n= 4), and we postulate that this was due to
P2X7 receptors. Combination of both az10606120 and suramin
nearly eliminated Ca2+ responses to BzATP in PSCs from both
WT (0.260.13, n= 4) and KO (0.060.07, n= 4) preparations.
Regarding effects of the broader acting agonist ATP, Ca2+
responses appeared lower in KO compared to WT PSC (but not
significant).
Discussion
In the present study we have successfully isolated PSCs by
a simplified method and studied their proliferation rate in response
to purinergic signals. Activated PSCs grow faster in the presence of
Figure 5. Differences in numbers of isolated and proliferating PSC cells. A. Number of isolated PSCs from pancreas of WT and KO mice
(n = 10). PSCs were counted immediately after isolation in 5 separate areas of the dish. B. Difference in proliferation of WT and KO PSC following
isolation and cell culture, as measured daily with Cell Counting Kit 8. (n = 3–5). Significant difference (P,0.05) between WT and KO (*) is indicated.
doi:10.1371/journal.pone.0051164.g005
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low concentrations of ATP. However, high ATP concentrations
are cytotoxic to these cells. Solid evidence is provided for
expression of the P2X7 receptors in PSCs. We propose that the
P2X7 receptor isoforms are involved in regulation of PSC viability
as discussed below.
PSCs isolated using a simplified method gave a substantial yield
of PSCs from a single mouse pancreas. As shown in Fig. 1, PSCs
were homogenous and had the same characteristics as determined
in previous studies using established methods of gradient
centrifugation [4] and outgrowth [5]. The homogenous expression
of a-SMA, GFAP and lipid granules in these cells shows that this
high-yield method of isolation is equivalent to established isolation
methods.
We clearly show that PSCs express the P2X7 receptor on
mRNA transcripts and protein level (Fig. 3B, C). All of the
receptor isoforms (A-D and K) found in mice are expressed in the
WT PSC (Fig. 3A). The KO PSCs also show mRNA for B–D
isoforms and the C-terminally truncated A and K hybrid isoforms.
Notably, PSCs from P2X7R KO mice also contained transcripts
for the mRNA upstream relative to the 85 nucleobases in P2X7R
that were replaced by the NeoR-plasmid insert. This expression
profile of the P2X7 receptor is probably also relevant for other
tissues. Our study indicates that the B (or C) isoform protein is
Figure 6. Effect of endogenous ATP and serum on PSCs
proliferation. A. Comparison of the DNA incorporation in WT and
KO PSCs with and without 5 U/ml apyrase. All samples contained 1%
serum (n= 9–23). Y-axis shows the BrdU incorporation in relative light
units. In the presence of apyrase, there was no significant difference
between proliferation of WT and KO cells. Significant difference
(P,0.05) from respective controls (#) and between WT and KO (*) is
indicated. B. Effect of serum on DNA incorporation in WT PSCs.
Significant difference (P,0.05) from 1% serum controls (#) and
between 0% and 0% serum with 5 mM ATP (1) is indicated.
doi:10.1371/journal.pone.0051164.g006
Figure 7. ATP can stimulate life and death in PSCs. A. Effect of
ATP in growth medium with 1% serum on BrdU incorporation in WT
PSCs (n = 6–23). B. Effect of selected ATP concentrations (mM) on BrdU
incorporation in WT and KO PSCs both normalized to their respective
0 ATP controls (n = 7–23). BrdU incorporations were normalized to 1%
serum conditions for the respective cell type. Significant difference
(P,0.05) from respective controls (#) and between WT and KO (*) is
indicated.
doi:10.1371/journal.pone.0051164.g007
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expressed, as we detect a band at the expected size of 60 kDa in
the Western blot with the extracellular antibody (Fig. 3C). This is
highly relevant as the isoforms can be partially responsible for the
proliferation effect in KO PSCs, and at least the B isoform has
been implicated as a growth promoter [20]. In addition to the
expressed B or C protein detected, we cannot determine the
identity of the higher molecular weight bands. These could
contain P2X7 protein coded by the transcript for either the
isoforms KO A or K hybrids, B or C, as all of these versions will be
recognized by the extracellular antibody. This is also the
conclusion reached in a recent paper re-evaluating the P2X7
receptor expression in P2X7R KO mice by Masin et al. [29].
Interestingly, using immunocytochemistry we find that the
P2X7 receptor antibody shows marked intracellular locations in
both KO and WT PSC, which could be due to receptor
desensitization during preparation. This has been seen regularly
with P2X7R staining [32] and P2X7R-EGFP expression [33].
Intracellular hotspot staining is similar to that found for many
other receptors, for example GABA [34]. Although this in-
tracellular staining could be unspecific, we also see a clear
membrane stain in the WT cells that is not observed in the KO
cells (Fig. 3B). We also performed a functional assay of the P2X7
receptor using Ca2+ imaging (Fig. 9). Interestingly, there was still
a response to BzATP in KO PSCs, but this could not be inhibited
by the P2X7 receptor blocker az10606120 as it could for the WT
PSCs. This supports the notion that the major P2X7 receptor
isoform, possibly B or C, is not functioning as a cation channel in
KO PSCs. The possible explanation for the BzATP effects in KO
cells is that it could be mediated by other purinergic receptors,
such as the P2X1 receptor that has affinity for this agonist [35], or
that expressed isoforms are not sensitive to az10606120 inhibitor.
Several of our experiments show that the P2X7 receptor in WT
PSCs is a death receptor when exposed to high ATP concentra-
tions (Fig. 4, 7). However, PSCs from KO animals do not undergo
cell death under the same conditions. This illustrates that the main
receptor phenotype supposedly altered in the KO mice is correct
and cells escape death. The protein site where the ‘‘death
sequence’’ is located is most likely in the KO region (506aa-
532aa) of the C-terminal. In this region, there is a sequence that is
similar to the TNF-Receptor1 death domain (436aa-531aa) [36].
The KO receptor data in PSCs strengthen the prediction about
the death region in the A and K isoform C-termini. Our
experiments also indicate that cell death in PSCs might be of
a necrotic character (Fig. 4 C, D), which has also been seen in
other studies [15,16].
One of the most important outcomes of our study is that the full
length P2X7 receptor (A and/or K isoform) is important for
optimal regulation of proliferation in PSCs. Firstly, in vivo PSCs
isolated from KO mice were about 50% lower in numbers
compared with cells isolated from the WT mice (Fig. 5A). This
agrees with the study of Glas et al. [37], who found fewer
pancreatic b-cells in the P2X7 receptor KO animals. Clearly, the
lower number of cells from the KO tissue would not be expected if
the main effect of the P2X7 receptor was that of a death receptor.
Since the KO cells lack the full length P2X7 receptor, and there is
Figure 8. Effect of BzATP, A438079 and az10606120 on
proliferation of PSC. A. The effect of BzATP on WT and KO PSCs
(n = 6–7). All results were normalized to 1% serum controls that were set
to 100%. The effect of: B. the P2X7 receptor A438079 inhibitor (10 mM);
C. and negative allosteric modulator az10606120 (10 mM) on the basal
proliferation response and in WT PSCs stimulated state with 100 mM
ATP (n = 4–23). Significant difference (P,0.05) from respective controls
(#) and with/without the inhibitor (*) is indicated.
doi:10.1371/journal.pone.0051164.g008
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a lower number of PSCs, we argue that the main property of the
P2X7 receptor is to maintain proliferation of these cells in
pancreas. Secondly, in vitro the KO PSCs grow much slower than
WT PSCs as verified by several protocols (Fig. 5, 6).
Basal ATP release occurs in many cells [38]. In apyrase
experiments we show that endogenous ATP is important for
proliferation of PSC (Fig. 6A). Since this is the case for both WT
and KO cells, one could infer that the isoforms expressed in KO
PSCs, potentially the B or C variant detected, can partly
compensate for the loss of potentiating effect of the full length
P2X7 receptor (see below).
In order to simulate a stimulatory autocrine or paracrine release
of ATP, exogenous ATP was added to PSCs. Most importantly,
proliferation of PSCs was stimulated with ATP concentrations up
to 100 mM (Fig. 7). We suggest that the basic proliferative response
is mediated by either one of the truncated isoforms B or C, or
potentially a KO A and K version, which has a truncated C-
terminal. The N-terminal of the P2X7 receptor, which is still
present in the KO, could transduce proliferative signaling via
ERK1/ERK2 [33]. Nevertheless, for the full proliferative effects of
exogenous and endogenous ATP seen in WT cells, the full length
P2X7 receptor is required. Together, these are therefore the first
experiments that illustrate the proliferation potential of the P2X7
isoforms in native cells. Our findings are consistent with the
reports of Adinolfi et al. on HEK293 cells transfected with the
P2X7 receptor [20] and Monif et al. on glial cells transfected with
the P2X7 receptor [39]. Our PSCs do also require some serum for
growth (Fig. 6B), perhaps because they are primary cells.
Both the proliferative and death effects of the P2X7 receptor in
PSCs are supported by pharmacological data, which give new
insights. BzATP stimulated proliferation in WT PSCs with about
tenfold higher potency than ATP (Fig. 8A), implicating a P2X7
receptor effect. However, in KO PSCs, the proliferation effect of
BzATP was small and also lower compared to ATP. Amstrup and
Novak [33] illustrated that a DC from Ser365 showed smaller
Ca2+ response to BzATP, but ATP effect was unchanged, which
could indicate that the C-terminal is important for Ca2+ signaling
transduction. The competitive blocker A438079 inhibited cell
death in PSCs, but the effect on proliferation was marginal
(Fig. 8B). The negative allosteric modulator az10606120, on the
other hand, had significant effect on growth induced by
micromolar ATP concentrations (Fig. 8C). These data agree well
with the intracellular Ca2+ measurements showing that the
az10606120 significantly inhibited response in WT PSCs (Fig. 9
C).
It is possible that the effect of ATP on proliferation could differ
from the ATP effect on pore formation and cell death due to
different binding sites on the receptor. In accordance, Klapper-
stu¨ck et al. [40] showed that there are two high sensitivity binding
sites for ATP (4 mM) and two low sensitivity binding sites for ATP
(200 mM) on the P2X7 receptor. The high sensitivity signal was
dependent on both the N- and C-terminal for full transduction,
while the low sensitivity only depended on the C-terminal.
Therefore we propose, based on the KO data, that the high
sensitivity site still can transduce some signal, and that BzATP
might not be such a good ligand for this site. This is also confirmed
by the Ca2+ imaging data, which showed significantly lower
response to BzATP in KO compared with WT PSCs. We also
conclude that the competitive inhibitor, A438079, is most likely
binding to the low sensitivity site and might not be a good
antagonist in respect to proliferation. The negative allosteric
modulator, az10606120, has on the other and huge impact on the
proliferation, suggesting that it modulates the high sensitivity site.
Based on the present in vitro experiments, extracellular ATP is
an important proliferation regulator in PSCs. How can this be
transferred to the in vivo situation? PSCs are located around the
acinar cells [4], suggesting that their main function is related to
their interplay with these cells. In a normal physiological situation
acinar cells release zymogen granules containing digestive enzymes
to the pancreatic duct lumen. In case of pancreatic damage, some
zymogen granules could release their cargo the basolateral side of
the acinus [41]. We have shown that zymogen granules
accumulate ATP via VNUT/Slc17a9 transporter and thus contain
ATP at concentrations that could activate purinergic receptors on
surrounding cells [42]. Thus, when mild pancreatic damage
occurs, we propose that PSCs proliferation that involves the P2X7
receptor would be stimulated to protect the damaged area. Hoque
at al. [43] illustrated that P2X7 receptor KO mice, were less
susceptible to develop maximal acute pancreatitis, however, they
postulate that it was due to lack of expression of P2X7 on
macrophages. The cytolytic effect of ATP is more difficult to
explain. We propose that a massive damage and disruption of
acinar cells and release of intracellular ATP (3–5 mM) can lead to
the death of PSCs, presumably by ‘‘overstimulated’’ P2X7
receptors. The cytolytic P2X7 receptors stimulated in macro-
phages release IL-1b [27,44]. It is a possibility that PSCs can
convert the death signal of high ATP concentrations, into an
interleukin release, which further activates and attracts other PSCs
and immune cells. Whether the P2X7 receptor releases the
interleukins, or whether it causes the cleavage of the propeptide,
remains to be investigated.
Conclusion
In conclusion, we show that basal and added ATP stimulated
proliferation in PSCs. This effect is mediated by the P2X7
receptor, and maximal proliferation is obtained with 100 mM
ATP. This effect and Ca2+ signaling could be inhibited by the
specific P2X7 antagonist az10606120. We propose that the full
proliferation effect requires the full length P2X7R isoform A or K.
Nevertheless, since the KO PSCs show about half of the maximal
proliferative response to endo/exogenous ATP, either KO A or K
hybrid versions, or isoforms B or C are also involved. Since we find
the expression of B or C variant proteins, we deem the latter more
likely. At high ATP concentrations, exceeding 1 mM, the
cytotoxic effect of ATP is dominating and the WT PSCs but not
the KO cells die, and this could be partially inhibited by the
antagonist A438079. Therefore, the C-terminal of the P2X7
receptor is necessary for the death signal.
Together this study presents strong evidence that ATP and the
P2X7 receptors are important regulators of both life and death of
PSCs, and therefore might be potential targets for treatments of
Figure 9. Calcium responses to BzATP and ATP in WT and KO PSC. The Fluo-4 response (Ft/F0) of WT (A–D) and KO (E–H) PSCs stimulated
with 50 mM BzATP, 50 mM ATP and lastly with 5 mM ionomycin. Intracellular Ca2+ signals were monitored in control conditions (A, E), in presence
az101606120 (B, F), suramin (C, G) and suramin together with az10606120 (D, H). The figures illustrate one independent representative run with the
frame average for about 50 cells in black, and an example response of 5 individual cells is shown in color. The peak intracellular Ca2+ responses to
agonists +/2 antagonists derived from frame intensities for approximately 50 cells/preparation were averaged for 4 separate PSCs preparations form
WT and KO mice and shown as bargraphs. The letters underneath the bars show from which experiment (indicated by a letter) the mean Ca2+ peak
values were taken from. Significant difference (P,0.05) from respective controls (#) and in between WT and KO preparations (*) is indicated.
doi:10.1371/journal.pone.0051164.g009
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pancreatic fibrosis and PSC interactions with other cells, for
example, in the development of pancreatic ductal adenocarcino-
ma.
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